Efficacy of liraglutide on glycemic endpoints in people of Western European and South Asian descent with T2DM using multiple daily insulin injections: results of the MAGNA VICTORIA studies.
Maurice B BizinoIngrid M JazetHuub J van EykPatrick C N RensenPetronella H Geelhoed-DuijvestijnAan V KharagjitsinghElisabeth H M PaimanJohannes W SmitHildebrandus J LambPublished in: Acta diabetologica (2021)
Liraglutide treatment resulted in increased chance of reaching target HbA1c as compared to placebo. Liraglutide efficacy was sustained in participants using MDI regimens and those of SA descent. Liraglutide should be considered for T2DM people with inadequate glycemic control despite MDI.